Diagnostic BioSystems Launches the First Automated IHC Multiplex Platform for Anatomic Pathology

3/19/2012 6:15:54 AM

PLEASANTON, Calif.--(BUSINESS WIRE)--Diagnostic Biosystems (DBS), a specialty Immunohistochemistry company, announces its debut as an automated IHC company, introducing the Mosaic 360™ System with a product offering of novel Multiplex Immunohistochemistry kits and a complementary line of optimized IHC reagents.

Read at BioSpace.com

Read Article at

Related Companies

News Categories

• BioSpace.com

• Diagnostic BioSystems

• Diagnostics

• Medical Devices

• Medical Dev. & Diag. - Product News